Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Understanding and Modulating Cortical Dynamics of Dual-task Standing in Older Adults With Mild Cognitive Impairment
Authors not listed
Hebrew SeniorLife · 2023
Abstract
The investigators have designed a brain stimulation study to understand its effect on an individual's standing, walking, and thinking abilities in older adults with and without mild cognitive impairments (MCI). The transcranial alternating current stimulation (tACS) technology has been safely and effectively used in hundreds of individuals. The purpose of this study is to test whether a single session of tACS as compared to sham intervention, improves standing, walking, and thinking in older adults with and without mild cognitive impairments (MCI). Approximately 60 people will take part in this study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Anonymous. (2023). Understanding and Modulating Cortical Dynamics of Dual-task Standing in Older Adults With Mild Cognitive Impairment. <em>Hebrew SeniorLife</em>. https://clinicaltrials.gov/study/NCT05680701
Vancouver
Anonymous. Understanding and Modulating Cortical Dynamics of Dual-task Standing in Older Adults With Mild Cognitive Impairment. Hebrew SeniorLife. 2023.
BibTeX
@misc{anon2023Unders,
title = {Understanding and Modulating Cortical Dynamics of Dual-task Standing in Older Adults With Mild Cognitive Impairment},
author = {Anonymous},
journal = {Hebrew SeniorLife},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Florida 2024
Open access · US-GOV
Neuromodulation Effects in Older Adults
University of Florida 2015
Open access · US-GOV
Revitalize Cognition: A Proof of Concept Study Using Transcranial Near Infrared Stimulation in Older Adults
Miracle Biomedical Co., Ltd. 2026
Open access · US-GOV
A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of MiraMSC Administered Intravenously in Elderly Subjects With Mild to Moderate Frailty Syndrome
Novartis 2003
Open access · US-GOV
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
University of Sheffield 2024
Open access · US-GOV
Effects of Different Parameter Settings on the Classification Accuracy of P300-BCI Speller in Elderly Adults with and Without Mild Cognitive Impairments
McGill University 2021
Open access · US-GOV